Philip C. Comp

3.9k total citations · 1 hit paper
48 papers, 2.9k citations indexed

About

Philip C. Comp is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Internal Medicine. According to data from OpenAlex, Philip C. Comp has authored 48 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cardiology and Cardiovascular Medicine, 22 papers in Hematology and 21 papers in Internal Medicine. Recurrent topics in Philip C. Comp's work include Venous Thromboembolism Diagnosis and Management (21 papers), Blood Coagulation and Thrombosis Mechanisms (15 papers) and Atrial Fibrillation Management and Outcomes (13 papers). Philip C. Comp is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (21 papers), Blood Coagulation and Thrombosis Mechanisms (15 papers) and Atrial Fibrillation Management and Outcomes (13 papers). Philip C. Comp collaborates with scholars based in United States, Canada and France. Philip C. Comp's co-authors include Eberhard Mammen, Jeffrey S. Ginsberg, Jay R. Lieberman, Charles W. Francis, Richard J. Friedman, Gary E. Raskob, Darla Liles, Edward C. Larkin, W. Keith Hoots and Robert C. Gosselin and has published in prestigious journals such as New England Journal of Medicine, Circulation and Blood.

In The Last Decade

Philip C. Comp

47 papers receiving 2.8k citations

Hit Papers

Oral Thrombin Inhibitor Dabigatran Etexilate vs North Ame... 2008 2026 2014 2020 2008 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip C. Comp United States 20 1.4k 1.4k 691 664 305 48 2.9k
Raymond Verhaeghe Belgium 20 536 0.4× 436 0.3× 287 0.4× 931 1.4× 298 1.0× 64 2.0k
J. Constans France 28 517 0.4× 492 0.4× 246 0.4× 715 1.1× 400 1.3× 155 2.8k
Jozef Arnout Belgium 25 499 0.3× 223 0.2× 660 1.0× 499 0.8× 155 0.5× 78 2.3k
Scott H. Goodnight United States 24 472 0.3× 321 0.2× 493 0.7× 698 1.1× 170 0.6× 60 2.5k
Alexander Spiel Austria 25 855 0.6× 312 0.2× 450 0.7× 408 0.6× 372 1.2× 81 2.6k
Sabine Steiner Austria 35 1.6k 1.1× 545 0.4× 297 0.4× 1.4k 2.1× 564 1.8× 145 4.0k
Thomas Pernerstorfer Austria 23 395 0.3× 268 0.2× 395 0.6× 354 0.5× 411 1.3× 58 1.7k
Cristina Novembrino Italy 22 233 0.2× 327 0.2× 339 0.5× 300 0.5× 211 0.7× 72 2.5k
Julie Brittenden United Kingdom 28 690 0.5× 445 0.3× 74 0.1× 1.4k 2.2× 219 0.7× 104 2.9k
C. Conri France 19 344 0.2× 268 0.2× 171 0.2× 314 0.5× 156 0.5× 62 1.5k

Countries citing papers authored by Philip C. Comp

Since Specialization
Citations

This map shows the geographic impact of Philip C. Comp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip C. Comp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip C. Comp more than expected).

Fields of papers citing papers by Philip C. Comp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip C. Comp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip C. Comp. The network helps show where Philip C. Comp may publish in the future.

Co-authorship network of co-authors of Philip C. Comp

This figure shows the co-authorship network connecting the top 25 collaborators of Philip C. Comp. A scholar is included among the top collaborators of Philip C. Comp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip C. Comp. Philip C. Comp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Acree, Luke S., Philip C. Comp, Thomas L. Whitsett, et al.. (2007). The influence of obesity on calf blood flow and vascular reactivity in older adults. PubMed. 6(1). 4–4. 23 indexed citations
3.
Dunn, S. Terence, et al.. (2006). Abnormal melt curve profile during prothrombin 20210G → A analysis due to the 20209C → T variant. Blood Coagulation & Fibrinolysis. 17(7). 599–602. 4 indexed citations
5.
Kinasewitz, Gary T., S. Betty Yan, Bruce R. Basson, et al.. (2004). Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]. Critical Care. 8(2). 291 indexed citations
6.
Hensley, Kenneth, Roberto Bolli, Philip C. Comp, et al.. (2003). New perspectives on vitamin E: γ-tocopherol and carboxyethylhydroxychroman metabolites in biology and medicine. Free Radical Biology and Medicine. 36(1). 1–15. 244 indexed citations
7.
Comp, Philip C.. (2003). Selective Factor Xa Inhibition Improves Efficacy of Venous Thromboembolism Prophylaxis in Orthopedic Surgery. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 23(6). 772–787. 6 indexed citations
8.
Francis, Charles W., Scott D. Berkowitz, Philip C. Comp, et al.. (2003). Comparison of Ximelagatran with Warfarin for the Prevention of Venous Thromboembolism after Total Knee Replacement. New England Journal of Medicine. 349(18). 1703–1712. 241 indexed citations
9.
Comp, Philip C., Theodore E. Spiro, Richard J. Friedman, et al.. (2001). Prolonged Enoxaparin Therapy to Prevent Venous Thromboembolism After Primary Hip or Knee Replacement. Journal of Bone and Joint Surgery. 83(3). 336–345. 166 indexed citations
10.
Rudnicka, Alicja R., et al.. (2001). An Association Between Plasma Free Protein S Concentration and Risk of Coronary Heart Disease in Middle-Aged Men. Thrombosis Research. 101(2). 1–11. 14 indexed citations
11.
Comp, Philip C., et al.. (1999). Hyperhomocysteinemia, Aortic Thrombus, and Peripheral Arterial Emboli. Angiology. 50(7). 599–603. 6 indexed citations
12.
Burstein, Samuel A., Paul Friese, Roman F. Wolf, et al.. (1996). Cytokine–Induced Alteration of Platelet and Hemostatic Function. Stem Cells. 14(S1). 154–162. 57 indexed citations
13.
Williams, Sybil B., et al.. (1996). Acquired hypoprothrombinemia: Effects of Danazol® treatment. American Journal of Hematology. 53(4). 272–276. 10 indexed citations
14.
Eichner, June E., William Moore, Patrick A. McKee, et al.. (1996). Fibrinogen levels in women having coronary angiography. The American Journal of Cardiology. 78(1). 15–18. 11 indexed citations
15.
Lane, Daniel M., Walter J. McConathy, Philip C. Comp, et al.. (1995). Selective removal of plasma low density lipoprotein with the HELP system: biweekly versus weekly therapy. Atherosclerosis. 114(2). 203–211. 18 indexed citations
16.
Raskob, Gary E. & Philip C. Comp. (1994). Preventing Systemic Embolism in Patients with Abnormal Ventricular Function. Cardiology Clinics. 12(3). 477–485. 1 indexed citations
17.
Comp, Philip C. & Howard A. Zacur. (1993). Contraceptive choices in women with coagulation disorders. American Journal of Obstetrics and Gynecology. 168(6). 1990–1993. 16 indexed citations
18.
Lane, Daniel M., Walter J. McConathy, Philip C. Comp, et al.. (1993). Weekly treatment of diet/drug-resistant hypercholesterolemia with the heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) system by selective plasma low-density lipoprotein removal. The American Journal of Cardiology. 71(10). 816–822. 14 indexed citations
19.
Comp, Philip C.. (1984). Animal Studies of Protein C Physiology. Seminars in Thrombosis and Hemostasis. 10(2). 149–153. 8 indexed citations
20.
Comp, Philip C. & Gabriel Lester. (1971). Properties of an Extracellular β-Galactosidase Secreted by Neurospora crassa. Journal of Bacteriology. 107(1). 162–167. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026